Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: A phase II trial
β Scribed by Dirk De Ruysscher; Robert-Harm Bremer; Friederike Koppe; Stofferinus Wanders; Erik van Haren; Monique Hochstenbag; Wiel Geeraedts; Cordula Pitz; Jean Simons; Guul ten Velde; Jo Dohmen; Gabriel Snoep; Liesbeth Boersma; Tom Verschueren; Angela van Baardwijk; Cary Dehing; Madelon Pijls; Andre Minken; Philippe Lambin
- Book ID
- 118496735
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 140 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limitedβdisease smallβcell lung cancer (LDβSCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LDβSCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,